Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if replacing melatonin function with a melatonin
agonist (ramelteon) in individuals that lack endogenous melatonin production (tetraplegia)
helps to alleviate self-reported sleep disruption.
Phase:
Phase 4
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development